Literature DB >> 16328032

Temporal cDNA microarray analysis of gene expression in human hepatocellular carcinoma upon radiation exposure.

Jaemin Jeong1, Su-Jin Hong, Yeun-Jin Ju, Bu-Yeo Kim, Myung-Jin Park, Tae-Hwan Kim, Chul-In Park, Kang-Yell Choi, Myung-Haeng Cho, Sang-Hoon Kim, Hansoo Lee, Kee-Ho Lee.   

Abstract

Radiotherapy is not commonly used for the treatment of human hepatocellular carcinoma, due to its poor response rate and poor tolerance of normal liver to ionizing radiation. Recently developed microarray technology makes it possible to verify genes responsive to anticancer therapy of human cancers by simultaneous analysis of gene expression profiles. In the present study, the expression profile of radiation-responsive genes in human hepatocellular carcinoma was evaluated through time-dependent cDNA microarray analysis of expressional variation, following exposure to ionizing radiation. Upon exposure to radiation, more than 13% of genes in both radiation-resistant and -sensitive cells responded to radiation. Time-dependent analysis of radiation-responsive genes revealed that, irrespective of radiation sensitivity, greatly different subsets of genes sequentially participated in cellular response to radiation at their specific activation or deactivation time points. The majority of radiation-responsive genes were differentially but not commonly expressed between radiation-resistant and -sensitive cells. When these differentially regulated genes were classified according to their physiological and functional characteristics and radiation sensitivity, it was prominently obvious that DNA repair-promoting genes were up-regulated in radio-resistant cells and down-regulated or unchanged in radiation-sensitive cells. The present findings indicate that different subsets of genes are sequentially working and DNA repair capacity may control the radiation sensitivity of human hepatocellular carcinoma cells more than any other physiological factor.

Entities:  

Mesh:

Year:  2006        PMID: 16328032

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy.

Authors:  Vesna Bišof; Antonija Jakovčević; Sven Seiwerth; Zoran Rakušić; Slavko Gašparov
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-26       Impact factor: 4.553

2.  Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma.

Authors:  Xian Lin; Lianxiang Luo; Yujiao Zou; Jian Chen
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

3.  Analysis of gene expression in normal and cancer cells exposed to gamma-radiation.

Authors:  M Ahmad Chaudhry
Journal:  J Biomed Biotechnol       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.